Fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography evaluation of subcutaneous panniculitis-like T cell lymphoma and treatment response

Figure 1 Case 1. A: Before treatment, showing multiple confluent pathological foci of hypermetabolic activity in subcutaneous fat (the largest are indicated by arrows on the whole-body image) and pathological foci in the breasts (in transverse sections); B: After 6 cycles of the CHOP regimen, showing no changes in the follow-up examinations, with conservation of previously defined lesions and development of new ones in the subcutaneous tissue (indicated by arrows on the whole-body image) and pathological focus of hypermetabolic activity which had developed in the mesentery of the descending colon (indicated by circles, on the whole-body image as well); C: After 6 cycles of the GEM-P chemotherapy regimen, showing marked improvement, as indicated by resorption of all previously defined foci. CHOP: Cyclophosphamide, doxorubicine, vincristine and prednisolone; GEM-P: Gemcitabine, cisplatin and methylprednisolone.